MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Histogenics Corp Company Profile (NASDAQ:HSGX)

Consensus Ratings for Histogenics Corp (NASDAQ:HSGX) (?)
Ratings Breakdown: 1 Hold Rating(s), 3 Buy Rating(s)
Consensus Rating:Buy (Score: 2.75)
Consensus Price Target: $12.13 (518.62% upside)

Analysts' Ratings History for Histogenics Corp (NASDAQ:HSGX)
Show:
DateFirmActionRatingPrice TargetActions
5/15/2016BTIG ResearchReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/12/2016Canaccord GenuityReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/13/2015Cowen and CompanyLower Price TargetOutperform$17.00 -> $12.50View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/13/2015Needham & Company LLCLower Price TargetBuy$17.00 -> $15.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 5/26/2014 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha